Algorithmic tool may improve screening of patients for an Alzheimer's clinical trial
Researchers have developed a blood-based screening algorithm that significantly reduces the need for expensive PET scans when identifying candidates for Alzheimer's clinical trials. This method helps streamline the recruitment process for testing early-stage treatments.
Why it matters
Improving trial recruitment efficiency is essential for accelerating the development of treatments for neurodegenerative diseases.
edited by Gaby Clark , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: https://kaboompics.com/ from Pexels A new blood-based screening algorithm dramatically reduced the number of unnecessary PET scans needed to recruit patients at risk of Alzheimer's disease for a clinical trial, according to research from scientists at the Keck School of Medicine of USC published in the journal Alzheimer's & Dementia .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in